|
⚲
|
| Keyboard |
| Gall Matthew
✚
|
|
|---|---|
| CIK # | 0001816194 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001816194] | |
| 4 | [0001816194] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gall Matthew | |
| Tango Therapeutics Inc | |
| Kalaris Therapeutics Inc | |
| iTeos Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
|
2026-03-19 | Grant | 95,000 | $0.00 | |
|
Kalaris Therapeutics Inc KLRS
Stock Option (Right to Buy) · derivative
|
2025-11-03 | Grant | 235,000 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2025-03-07 | Grant | 24,000 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2025-03-07 | Grant | 145,000 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2024-11-19 | Buy | 5,000 | $7.73 | 38,650 |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2024-03-07 | Grant | 163,200 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2023-12-05 | Grant | 41,000 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2023-10-12 | Buy | 5,000 | $8.37 | 41,850 |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2023-03-09 | Grant | 130,000 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2022-03-11 | Grant | 85,000 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2021-12-27 | Sell | 5,000 | $46.45 | 232,250 |
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2021-10-11 | Option exercise | 14,429 | $6.16 | 88,883 |
|
iTeos Therapeutics Inc ITOS
Stock Option (right to buy) · derivative
|
2021-10-11 | Option exercise | 14,429 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2021-06-24 | Grant | 24,000 | $0.00 | |
|
iTeos Therapeutics Inc ITOS
Common Stock
|
2021-06-16 | Buy | 5,000 | $26.09 | 130,450 |
|
iTeos Therapeutics Inc ITOS
Stock Option (Right to Buy) · derivative
|
2021-03-01 | Grant | 72,000 | $0.00 |